Albemarle expands its Fine Chemistry Services facility in South Haven, Michigan

    Albemarle expands its Fine Chemistry Services facility in South Haven,
                                   Michigan

PR Newswire

BATON ROUGE, La., Oct. 21, 2013

BATON ROUGE, La., Oct. 21, 2013 /PRNewswire/ --Albemarle Corporation (NYSE:
ALB), a global developer, manufacturer and marketer of highly engineered
specialty chemicals and services, announced that it has expanded the kilo lab
at its FDA-registered cGMP active pharmaceutical ingredient (API) production
facility in South Haven, Michigan. Production using the new, expanded kilo lab
is expected in January 2014.

(Logo: http://photos.prnewswire.com/prnh/20111129/MM14279LOGO)

The expanded kilo lab will allow Albemarle to better focus on customers' needs
for smaller quantities of material specifically produced to cGMP guidelines.
Supporting the company's overall pharmaceutical custom synthesis offering, the
expansion will enable Albemarle to address customer requirements throughout
the entire life-cycle of their product, beginning from early stage clinical
development to full-scale commercial production. The kilo lab production unit
will operate within South Haven's cGMP standards and will be suitable for
production of API products.

Albemarle Fine Chemistry Services is equipped with the assets and experience
to fulfill demand requirements at all program phases, from grams and low
kilogram amounts to 50+ MT scale projects. The Company specializes in enabling
customers to go to market in an efficient and fully compliant manner by
providing comprehensive process development, scale-up and validation
capabilities followed by seamless transition into commercial-scale production.

About Albemarle
Albemarle Corporation, headquartered in Baton Rouge, Louisiana, is a leading
global developer, manufacturer, and marketer of highly-engineered specialty
chemicals for consumer electronics, petroleum refining, utilities, packaging,
construction, automotive/transportation, pharmaceuticals, crop protection,
food-safety and custom chemistry services. The Company is committed to global
sustainability and is advancing its eco-practices and solutions in its three
business segments, Polymer Solutions, Catalysts and Fine Chemistry. Corporate
Responsibility Magazine selected Albemarle to its prestigious "100 Best
Corporate Citizens" list for 2010, 2011 and 2013. Albemarle employs
approximately 4,200 people and serves customers in approximately 100
countries. Albemarle regularly posts information to www.albemarle.com,
including notification of events, news, financial performance, investor
presentations and webcasts, Regulation G reconciliations, SEC filings, and
other information regarding the Company, its businesses and the markets we
serve.

Albemarle's Fine Chemistry Services (FCS) division is an innovative,
full-service provider of fine chemicals to the world's leading companies
across the pharmaceutical, agrichemical, and specialty materials markets.
Albemarle's FCS division helps global customers complete hundreds of
successful projects through a powerful combination of proven chemistry
expertise, game-changing process development, high-quality custom
manufacturing and exceptional service. From innovative R&D to commercial-scale
production, Albemarle's FCS division delivers the knowledge, experience,
resources, creativity and service you need to move products to market faster
and accelerate your business. To learn more about Albemarle's FCS division,
please visit www.albemarle.com/fcs.

"Safe Harbor" Statement under the Private Securities Litigation Reform Act of
1995: Statements in this press release regarding Albemarle Corporation's
business that are not historical facts are "forward-looking statements" that
involve risks and uncertainties. For a discussion of such risks and
uncertainties, which could cause actual results to differ from those contained
in the forward-looking statements, see "Risk Factors" in the Company's Annual
Report on Form 10-K.

SOURCE Albemarle Corporation

Website: http://www.albemarle.com
Contact: Media Contact: Ashley Mendoza, (225) 388-7137,
Ashley.Mendoza@albemarle.com, Investor Relations Contact: Lorin Crenshaw,
(225) 388-7322, Lorin.Crenshaw@albemarle.com